The topical derma drugs industry will relinquish an approximated estimate at a frequency of 6.4% for the projection space of 2021 to 2028 with factor such as increasing prevalence of skin disorders and the rising prescription rate of generics drugs in the U.S.
Increasing collaboration among market players to strengthen the market in the U.S. region for product development and distribution has propelled the demand of the topical derma drugs market. However, the alternative to topical drugs for treatment and discontinuation and product recall in the U.S. has decreased the demand of the topical derma drugs market.
Topical Derma Drugs Market Scenario
According to Data Bridge Market Research, the market for topical derma drugs in the U.S. is growing with market leaders such as Teva Pharmaceuticals USA, Inc. (a subsidiary of Teva Pharmaceutical Industries Ltd.) which accounts an estimated market share of approximately 8% to 10%. The company has gained outstanding sale by providing branded products for topical derma drugs.
- In December 2018, Teva Pharmaceuticals USA, Inc. (a subsidiary of Teva Pharmaceutical Industries Ltd.) announced that they have launched Generic Version of Elidel (Pimecrolimus) Cream, 1% for skin disease. This has increased the product portfolio of the company in the U.S. topical derma drugs market.
Trends Impacting the Topical Derma Drugs Market
Now the question is which other regions Teva Pharmaceuticals USA, Inc. (a subsidiary of Teva Pharmaceutical Industries Ltd.), Taro Pharmaceutical Industries Ltd. and Ortho Dermatologics’ (a subsidiary of Bausch Health Companies Inc.) are targeting? Data Bridge Market Research has forecasted a large growth in the U.S. topical derma drugs market and the market leaders are targeting to be their next revenue pockets for 2021.
The U.S. topical derma drugs market is becoming more competitive every year with companies such as Teva Pharmaceuticals USA, Inc. (a subsidiary of Teva Pharmaceutical Industries Ltd.), Taro Pharmaceutical Industries Ltd. and Ortho Dermatologics’ (a subsidiary of Bausch Health Companies Inc.) which are the market leaders for topical derma drugs. The Data Bridge Market Research new reports highlight the major growth factors and opportunities in the U.S. topical derma drugs market.
For more analysis on the U.S. topical derma drugs market, request for a briefing with our analysts https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=us-topical-derma-drugs-market
Topical Derma Drugs Market Development
- In September 2020, Cipla Inc. had entered the anti-fungal product category with the launch of Clocip. It is a skin infection solution available in two forms: the Clocip Clotrimazole Absorbent Dusting Powder and Clocip Clotrimazole Cream. The product launch would result in distribution of the anti-fungal cream across hospitals and retail pharmacies. It would show a linear growth in the market.
Scope of the U.S. Topical Derma Drugs market
All country based analysis of the U.S. topical derma drugs market is further analyzed based on maximum granularity into further segmentation. On the basis of severity, the topical derma drugs market is segmented into mild to moderate and moderate to severe.
- On the basis of drug class, the topical derma drugs market is segmented into anti-fungal, corticosteroids, local anaesthetics, antibiotics, anti-virals, anti-acne agents, anti-itch agents, miscellaneous topical agents and others. On the basis of formulation, the topical derma drugs market is segmented into patches, gel, ointment, cream, foams and others. On the basis of site, the topical derma drugs market is segmented into surface of the skin, epidermis and / or dermis. On the basis of application, the topical derma drugs market is segmented into acne, cold sores, hives, actinic keratosis, carbuncle, rosacea, eczema, psoriasis, lupus, contact dermatitis, vitiligo, warts, ringworm impetigo and others. On the basis of population type, the topical derma drugs market is segmented into children and adults. On the basis of mode of purchase, the topical derma drugs market is segmented into prescription and over the counter (OTC). On the basis of end user, the topical derma drugs market is segmented into hospitals, specialty clinics and home healthcare and others. On the basis of distribution channel, the topical derma drugs market is segmented into hospital pharmacies, retail pharmacies, online pharmacies and others.
To know more about the study https://www.databridgemarketresearch.com/reports/us-topical-derma-drugs-market
Key Pointers Covered in Topical Derma Drugs Market Industry Trends and Forecast to 2028
- Market Size
- Top to Bottom Market Analysis
- Recent Developments for Market Competitors
- Recent Market Value for Different Countries
- Market Value and Over View
- Company Profiling of Top Players of Topical Derma Drugs
Key Market Competitors Covered in the Report
- Teva Pharmaceuticals USA, Inc. (a subsidiary of Teva Pharmaceutical Industries Ltd.)
- Taro Pharmaceutical Industries Ltd
- Ortho Dermatologics (a subsidiary of Bausch Health Companies Inc)
- Viatris Inc.
- Sandoz International GmbH (a subsidiary of Novartis AG)
- GALDERMA LABORATORIES, L.P. (a subsidiary of GALDERMA)
- GlaxoSmithKline plc
- Perrigo Company plc
- Accord Healthcare (a subsidiary of Intas Pharmaceuticals Ltd)
- Amneal Pharmaceuticals LLC
- Cipla Inc
- Dr Reddy’s Laboratories Ltd
- Encube Ethicals
- Glenmark Pharmaceutical Inc, USA (a subsidiary of Glenmark Pharmaceuticals Ltd)
- Lupin Pharmaceuticals, Inc (a subsidiary of LUPIN)
- Teligent
- Tolmar Pharmaceuticals, Inc
- Zydus Pharmaceuticals (a subsidiary of Zydus Cadila)
Above are the key players covered in the report, to know about more and exhaustive list of topical derma drugs companies’, contact us https://www.databridgemarketresearch.com/toc/?dbmr=us-topical-derma-drugs-market
Research Methodology: The U.S. Topical Derma Drugs Market
Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include vendor positioning grid, market time line analysis, market overview and guide, company positioning grid, company market share analysis, standards of measurement, top to bottom analysis and vendor share analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Primary Respondents
- Demand Side: Dermatologists, Doctors, Healthcare Professionals and Therapists.
- Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence and Regulatory Affairs Managers among others.
Related Reports
- Global Dermatology Drugs Market – Industry Trends and Forecast to 2028
- Global Dermatology Treatment Devices Market – Industry Trends and Forecast to 2027
- Global Dermatology Diagnostic Devices Market – Industry Trends and Forecast to 2028
Browse in Healthcare Category Related Reports@ https://www.databridgemarketresearch.com/report-category/healthcare/
